Publication | Closed Access

ERCC1 and BRAC1 mRNA Expression Levels in the Primary Tumor Could Predict the Effectiveness of the Second-Line Cisplatin-Based Chemotherapy in Pretreated Patients with Metastatic Non-small Cell Lung Cancer

Pretreated PatientsSecond-line Cisplatin-based ChemotherapyMedicinePathologyBronchial NeoplasmCancer TreatmentOncologyCell BiologyLung CancerTumor Biology